Nested balloon catheter for localized drug delivery

• US 8,348,890 B2
• Filed: 03/01/2011
• Issued: 01/08/2013
• Est. Priority Date: 03/01/2011
• Status: Active Grant

• Current Assignee: Sanovas Intellectual Property, LLC
• Original Assignee: Sanovas, Inc.
• Inventors: Gerrans, Lawrence J., Gunday, Erhan H.
• Primary Examiner(s): Lucchesi, Nicholas
• Assistant Examiner(s): BERDICHEVSKY, AARTI
• Application Number:
  US13/037,856
• Publication Number:
  US 20120226230A1
• Time in Patent Office: 679 Days
• Field of Search: 604/101.01, 604/101.02, 604/102.01
• US Class Current: 604/101.02
• CPC Class Codes: A61B 5/021 Measuring pressure in heart or blood vessels A61B5/0205 takes precedence
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61M 2025/1013 with concentrically mounted balloons, e.g. being independently inflatable
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 2025/1052 for temporarily occluding a vessel for isolating a sector
• CPC Class Codes: A61M 2025/1086 having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
• CPC Class Codes: A61M 25/1011 Multiple balloon catheters
• CPC Class Codes: A61M 25/10184 Means for controlling or monitoring inflation or deflation
• CPC Class Codes: A61N 5/0603 for treatment of body cavities
• CPC Class Codes: A61N 5/1014 Intracavitary radiation therapy

Abstract

A balloon catheter for delivering a therapeutic and/or diagnostic agent to tissue is described including an outer balloon having a wall with an opening therethrough and an inner surface, an inner balloon disposed in the outer balloon, enclosing an inflation chamber and having an outer surface defining a space between the outer surface of the inner balloon and the inner surface of the outer balloon, a catheter having a first lumen in fluid communication with the space between the inner balloon and the outer balloon for supplying the agent thereto, and a second lumen through which fluid is supplied to the inflation chamber for inflating the inner balloon to urge the agent out of the opening in the outer balloon, wherein the outer balloon and/or the inner balloon comprise at least one protrusion for directing the agent.

Claims

1. A balloon catheter for delivering a therapeutic and/or diagnostic agent to tissue, comprising:

an outer balloon having a wall with at least one opening therethrough and an inner surface;

an inner balloon at least partially disposed in said outer balloon, said inner balloon at least partially enclosing an inflation chamber and having an outer surface defining a space between the outer surface of said inner balloon and the inner surface of said outer balloon;

a catheter having

a first lumen in fluid communication with the space between the outer surface of said inner balloon and the inner surface of said outer balloon for supplying a therapeutic and/or diagnostic agent thereto; and

a second lumen through which fluid is supplied to the inflation chamber of said inner balloon for inflating said inner balloon to urge the therapeutic and/or diagnostic agent out of the at least one opening in the wall of said outer balloon and into tissue;

wherein at least one of said outer balloon and said inner balloon comprise at least one protrusion for directing the therapeutic and/or diagnostic agent; and

wherein the outer surface of said inner balloon comprises a first protrusion and a second protrusion, the first and second protrusions extending longitudinally and forming a channel therebetween, wherein an outer surface of said outer balloon comprises a third protrusion having an annular shape, and wherein the at least one opening in the wall of said outer balloon is enclosed by the third annular protrusion.

2. A balloon catheter for delivering a therapeutic and/or diagnostic agent to tissue, comprising:

an outer balloon having a wall with at least one opening therethrough and an inner surface;

an inner balloon at least partially disposed in said outer balloon, said inner balloon at least partially enclosing an inflation chamber and having an outer surface defining a space between the outer surface of said inner balloon and the inner surface of said outer balloon;

a catheter having

a first lumen in fluid communication with the space between the outer surface of said inner balloon and the inner surface of said outer balloon for supplying a therapeutic and/or diagnostic agent thereto; and

a second lumen in fluid communication with the inflation chamber of said inner balloon for supplying fluid thereto to inflate said inner balloon; and

a fluid source in fluid communication with said second lumen for inflating said inner balloon to urge the therapeutic and/or diagnostic agent out of the at least one opening in the wall of said outer balloon and into tissue;

wherein said fluid source supplies fluid to said second lumen in pulsed fashion to repeatedly inflate and at least partially deflate said inner balloon.

3. The balloon catheter of claim 2, wherein at least one of said outer balloon and said inner balloon comprise at least one protrusion for directing the therapeutic and/or diagnostic agent.

4. The balloon catheter of claim 3, wherein the at least one protrusion is formed by at least one of an inner balloon wall and the outer balloon wall.

5. The balloon catheter of claim 2, wherein the inner surface of said outer balloon comprises at least one protrusion for directing the therapeutic and/or diagnostic agent.

6. The balloon catheter of claim 2, wherein the outer surface of said inner balloon comprises at least one protrusion for directing the therapeutic and/or diagnostic agent.

7. The balloon catheter of claim 2, wherein said outer balloon has an outer surface and wherein the outer surface of said outer balloon comprises at least one protrusion for directing the therapeutic and/or diagnostic agent.

8. The balloon catheter of claim 2, wherein the inner surface of said outer balloon comprises a first protrusion having a shape, and the outer surface of said inner balloon comprises a second protrusion corresponding to the shape of the first protrusion to create a channel therebetween.

9. The balloon catheter of claim 2, wherein the wall of said outer balloon has an abrasive outer surface for abrading tissue.

10. The balloon catheter of claim 2, wherein said fluid source comprises an electro-pneumatic pump.

11. The balloon catheter of claim 10, further comprising a monitoring device for monitoring at least one patient vital sign, wherein said pump controls the pressure to which the inner balloon is inflated based at least in part on the monitored vital sign.

12. The balloon catheter of claim 10, further comprising a monitoring device for monitoring at least one patient vital sign, wherein said pump controls the supply of the therapeutic and/or diagnostic agent based at least in part on the monitored vital sign.

13. The balloon catheter of claim 2, wherein said fluid source further comprises a vacuum source that evacuates fluid from the inflation chamber.

14. The balloon catheter of claim 2, further comprising an imaging device disposed in said catheter for viewing tissue in a bodily cavity.

15. The balloon catheter of claim 2, further comprising at least one imaging marker mounted adjacent to said inner and outer balloons.

16. The balloon catheter of claim 2, wherein said catheter has a distal end with an opening therein and wherein said catheter has a third lumen in fluid communication with the opening for passing bodily fluids through the catheter.

17. The balloon catheter of claim 2, further comprising at least one sensor for measuring at least one characteristic of tissue.

18. The balloon catheter of claim 2, further comprising a distal balloon positioned distally of said inner and outer balloons and a proximal balloon positioned proximally of said inner and outer balloons, wherein said fluid source inflates the proximal balloon and the distal balloon by supplying fluid thereto to create a chamber therebetween.

19. The balloon catheter of claim 2, wherein an outer surface of the proximal and distal balloons comprises a textured surface for preventing slippage of the outer surface on tissue.

20. The balloon catheter of claim 2, wherein said fluid is a gas.

21. The balloon catheter of claim 2, wherein the wall of said outer balloon has an outer surface comprising a mesh sleeve of elastic yarn.

22. The balloon catheter of claim 21, wherein the mesh sleeve is radiopaque.

23. The balloon catheter of claim 2, wherein the agent is doxorubicin.

24. The balloon catheter of claim 2, wherein the agent comprises at least one of cisplatin and epinephrine.

25. The balloon catheter of claim 2, wherein the agent is 5-4 fluorouracil.

26. The balloon catheter of claim 2, wherein the agent is noscapine.

27. The balloon catheter of claim 2, wherein the agent is diltiazem augment taxol.

28. The balloon catheter of claim 2, wherein the agent is crizotinib.

29. The balloon catheter of claim 2, wherein the agent is erlotinib hydrochloride.

30. The balloon catheter of claim 2, wherein the agent is gefitinib.

31. The balloon catheter of claim 2, wherein the agent comprises drug eluting microspheres.

32. The balloon catheter of claim 2, wherein the drug eluting microspheres contain doxorubicin.

33. A method of localized delivery of a therapeutic and/or diagnostic agent to tissue, comprising the steps of:

inserting a catheter into a bodily cavity, said catheter comprising

an outer balloon having a wall with at least one opening therethrough and an inner surface; and

an inner balloon at least partially disposed in said outer balloon, said inner balloon at least partially enclosing an inflation chamber and having an outer surface defining a space between the outer surface of said inner balloon and the inner surface of said outer balloon;

supplying the therapeutic and/or diagnostic agent to the space between the outer surface of said inner balloon and the inner surface of said outer balloon via a first lumen of said catheter;

inflating said inner balloon by supplying fluid to the inflation chamber via a second lumen of said catheter to urge the therapeutic and/or diagnostic agent out of the at least one opening in the wall of said outer balloon and into tissue; and

repeatedly deflating and inflating said inner balloon by supplying fluid to the inflation chamber in pulsed fashion.

34. The method of claim 33, wherein the wall of said outer balloon has an abrasive outer surface, and wherein the step of inflating said inner balloon comprises contacting tissue in the bodily cavity with the abrasive surface such that it abrades the tissue.

35. The method of claim 33, wherein the step of delivering the therapeutic and/or diagnostic agent to tissue further comprises inflating said inner balloon until the wall of said outer balloon contacts tissue in the bodily cavity.

36. The method of claim 33, wherein the step of inflating said inner balloon comprises supplying fluid thereto with an electro-pneumatic pump.

37. The method of claim 33, further comprising the step of using an imaging device disposed in said catheter to visualize tissue in the bodily cavity.

38. The method of claim 33, further comprising the step of measuring at least one characteristic of tissue in the bodily cavity via at least one sensor.

39. The method of claim 33, wherein the agent is doxorubicin.

40. The method of claim 33, wherein the agent is cisplatin, and wherein the method further comprises the step of supplying a second agent, said second agent being epinephrine.

41. The method of claim 33, wherein the agent is 5-4 fluorouracil.

42. The method of claim 33, wherein the agent is noscapine.

43. The method of claim 33, wherein the agent is diltiazem augment taxol.

44. The method of claim 33, wherein the agent is crizotinib.

45. The method of claim 33, wherein the agent is erlotinib hydrochloride.

46. The method of claim 33, wherein the agent is gefitinib.

47. The method of claim 33, wherein the agent comprises drug eluting microspheres.

48. The method of claim 47, wherein the drug eluting microspheres contain doxorubicin.

49. The method of claim 33, wherein the agent is a combination of at least one therapeutic agent and at least one biomarker, and wherein the method further comprises the step of monitoring extravasation of the at least one therapeutic agent into tissue via the at least one biomarker.

50. The method of claim 49, wherein the biomarker is a radio-opaque marker.

51. The method of claim 33, wherein said catheter further comprises a distal balloon positioned distally of said inner and outer balloons and a proximal balloon positioned proximally of said inner and outer balloons, wherein the method further comprises the step of inflating the distal and proximal balloons by supplying fluid thereto via at least one additional lumen of said catheter to create a chamber between the distal and proximal balloons, and wherein the step of delivering the therapeutic and/or diagnostic agent comprises delivering the agent to said chamber.

52. The method of claim 33, wherein the step of delivering the therapeutic and/or diagnostic agent further comprises supplying the agent to a channel defined by a first protrusion provided on the inner surface of said outer balloon and a second protrusion provided on the outer surface of said inner balloon such that the agent is delivered to a localized area in the bodily cavity.

53. The method of claim 33, wherein the wall of said outer balloon has an outer surface comprising a mesh sleeve of elastic yarn.

54. The method of claim 53, wherein the mesh sleeve is radiopaque.